Home Contact

Featured Lecture

<< BACK
This PRESENT lecture is brought to you
by the generous sponsorship of

CLICK HERE FOR MORE INFORMATION

 

 Neuropathy  

By

Lawrence Lavery, DPM,FACFAS

Associate Professor
Texas A&M Health Science Center
College of Medicine
Scott and White Hospital
Temple, Texas

Podiatric Medicine and Surgery has evolved considerably over the last few years. Disorders which had eluded our best efforts are now readily treatable. Dr. Lawrence Lavery's presentation brings us to the state of the art in the treatment of peripheral neuropathy. It appears that we are on the brink of having remedies available to us. Our increasingly comprehensive understanding of peripheral neuropathy is bringing us to this point.

Sensory neuropathy (loss of protective sensation) is one of the strongest risk factors for both foot ulceration and amputation in a patient with diabetes. Nerve damage associated with diabetes involves axonal degeneration of myelinated and unmyelinated nerves and involves loss of both small and large nerve fibers.

Dr. Lavery discusses
the non-controllable risk factors:

bullet age
bullet duration of diabetes


and the controllable risk factors:

bullet hyperglycemia
bullet hypertension
bullet elevated cholesterol/triglycerides
bullet use of tobacco

The diagnosis of diabetic sensory neuropathy is made based on review of the signs and symptoms, the results of the physical examination and diagnostic studies. Dr. Lavery reminds us that the use of a single instrument (Semmes-Weinstein monofilaments, for example), is not sufficient to make a definitive diagnosis. Patients with nutritional deficiencies, anemia, radiculopathies, alcoholism and other conditions present with symptoms very similar to diabetic sensory neuropathy.

Dr. Lavery reviews the various screening tests that will help the practitioner make a correct diagnosis. Standard vibration perception, deep tendon reflexes, motor strength, sharp/dull discrimination and light touch should all be part of the initial examination. While these tests are valuable, their results are difficult to quantify.

The biothesiometer is a unique device which can provide semi-quantitative information about the level of vibration the patient can feel in their foot. The information gleaned from this device helps us better understand the benefits and effectiveness of our treatment.

The first step in the management of established diabetic neuropathy is to maintain good glycemic control. Patients who have undergone pancreatic transplantation have seen significant reversal in the neuropathy.

Monochromatic Near-Infrared Therapy, commonly known as Anodyne, has shown great promise. 98% of patients who received Anodyne Therapy for thirty minutes, three times weekly, had improvement after six weeks. The percentage of patients who saw improvement increased to one hundred percent, after twelve weeks of treatment. Dr. Lavery also discusses surgical decompression. This technique has shown great promise.  However, he feels that more research is needed before it is used on a widespread basis in this high risk population.

Be aware - The answer to the question, "Can you do anything for the numbness and burning in my foot?", is rapidly changing.
 

CLICK IMAGE BELOW TO VIEW LECTURE

VIEW LECTURE

 
Online Demo

PRESENT gives you the opportunity to see our system in action in this online demo.

 

Sign up now and receive the latest news and info from PRESENT. Perfect for all doctors that offer a residency program.

Testimonial

PRESENT has given me the help I need to run my practice AND a residency program!

Dr. Robert Smith, DPM
© 2003 PRESENT. All rights reserved.